Astex Joins Structural Biology Partnership at the European Synchrotron Radiation Facility
11 nov. 2002 04h18 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Nov. 11, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has joined the new Partnership for Structural Biology (PSB)...
Sectra Increases Customer Benefit Through New Partnership
05 nov. 2002 03h11 HE
|
Sectra
LINKOPING, Sweden, Nov. 5, 2002 (PRIMEZONE) -- The Swedish medical technology and IT company Sectra (Other OTC:SSBBF) (Stockholm:SECTb) has signed an agreement with the Swedish medical technology...
Astex Determines Structure of the Key Drug Metabolising Enzyme -- Human Cytochrome P450 3A4
28 oct. 2002 04h13 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 28, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has solved the 3-dimensional crystal structure of human cytochrome...
BioFocus and Xention Enter Cardiovascular Drug Discovery Collaboration
07 oct. 2002 07h33 HE
|
Xention
CAMBRIDGE, U.K. and Sittingbourne, Kent, U.K., Oct. 7, 2002 (PRIMEZONE) -- BioFocus plc (BioFocus), the collaborative drug discovery company and Xention Discovery Ltd. (Xention), the specialist ion...
Former AstraZeneca R&D Head Appointed New Chairman of Gyros AB
07 oct. 2002 03h45 HE
|
Gyros
UPPSALA SCIENCE PARK, Sweden, Oct. 7, 2002 (PRIMEZONE) -- Gyros AB today announced the appointment of Dr. Claes Wilhelmsson as chairman of the board. Dr. Wilhelmsson is the former Executive Director...
Change of CEO at Medivir
10 sept. 2002 03h26 HE
|
Medivir
HUDDINGE, Sweden, Sept. 10, 2002 (PRIMEZONE) -- Jonas Frick, CEO of Medivir since Stock Exchange listing in 1996, will leave the Company for a role as a Senior Partner of Scandinavian Life Science...
Biovitrum: Swedish Biotech Companies Form New Industry Organization -- 'SwedenBIO'
04 sept. 2002 04h48 HE
|
Biovitrum AB
STOCKHOLM, Sweden, Sept. 4, 2002 (PRIMEZONE) -- SwedenBIO is a new industry association that will work actively to promote the successful establishment of internationally competitive biotechnology...
Actelion to List on SWX Main Market on September 9, 2002; Trading Symbol ATLN Remains Unchanged; Full Quarterly Reporting to Continue
27 août 2002 01h49 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Aug. 27, 2002 (PRIMEZONE) -- Actelion (SWX:ATLN) announced today that company's bearer shares will list be listed on the SWX Main Market board as of Monday, September 9,...
CeNeS Announces Divestment of Its Ion Channel Technology Business
15 août 2002 04h12 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Aug. 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced the spinout of its ion channel technology development business (Channelwork) as part of the ongoing...
Newport Corporation Reports Second Quarter and Six-Month 2002 Results; Financial Performance in Line with Expectations
23 juil. 2002 16h15 HE
|
Newport Corporation
IRVINE, Calif., July 23, 2002 (PRIMEZONE) -- Newport Corporation (Nasdaq:NEWP) today reported financial results for the second quarter and six months ended June 30, 2002, reflecting continued...